LifeTech Scientific Corp 01302

Morningstar Rating
HK$1.35 +0.04 (3.05%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

01302 is trading within a range we consider fairly valued.
Price
HK$1.35
Fair Value
LOCK|FjC@Bd
Uncertainty
LOCK|P^D
1-Star Price
LOCK|s?vF<&
5-Star Price
LOCK|lffNPXZ
Economic Moat
LOCK|%^p
Capital Allocation
—

Trading Information

Previous Close Price
HK$1.31
Day Range
HK$1.31–1.41
52-Week Range
HK$1.26–2.38
Bid/Ask
HK$1.34 / HK$1.35
Shares Outstanding
4.40B
Market Cap
HK$5.94B
Volume/Avg
35M / 18M

Key Statistics

Price/Earnings (Normalized)
26.36
Price/Sales
4.15
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
1,254

Valuation

Metric
01302
Price/Earnings (Normalized)
26.36
Price/Book Value
1.51
Price/Sales
4.15
Price/Cash Flow
10.47
Price/Earnings
01302

Financial Strength

Metric
01302
Quick Ratio
1.83
Current Ratio
2.45
Interest Coverage
—
Quick Ratio
01302

Profitability

Metric
01302
Return on Assets (Normalized)
4.56%
Return on Equity (Normalized)
6.56%
Return on Invested Capital (Normalized)
6.06%
Return on Assets
01302

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|!^@fjybLOCK|z@$<?$172B
Medtronic PLC
MDT
LOCK|>Ms>$HLOCK|l#zT$113B
Stryker Corp
SYK
LOCK|$!bsmBlQLOCK|Fr?$106B
Boston Scientific Corp
BSX
LOCK|^LVk#^LOCK|K#xm!$62B
Edwards Lifesciences Corp
EW
LOCK|^<NZF^%tLOCK|KF%X$49B
DexCom Inc
DXCM
LOCK|?&$$!twrLOCK|n?G!?$32B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|T%BqzcLOCK|K#&$30B
Koninklijke Philips NV ADR
PHG
LOCK|k?LOCK|z%>$24B
Steris PLC
STE
LOCK|tJ$&%CLOCK|^R@>&$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|@!XjQYxLOCK|bm$17B

Sponsor Center